Rivulet Media Inc (fka RIVU)

[T_T23]

That is precisely the point "doesn't look good" so he is honest???? so when he said they will release the medical peer review publication, file for IND and then begin clinical trial in 2013-2014 you should of believe him and would of made a lot of cash (enough to make back the cash you lost on that crappy stock ENTB)....also check out the other development bio-stock (even the ones on the NASDAQ exchange), their revenue are also in the negative (some even at thousand of percentage).....like I told you before, these bio company don't make money until sell the patent/drug design for 100M+ or release the drug to the market (which will cost 100Ms in the process and make 1B+ a year on it).